Article
Mutation screening of the CHRNA4 and CHRNB2 nicotinic cholinergic receptor genes in Alzheimer's disease.
Neuroreport - 29 Sept 1999
Steinlein O K, Stoodt J, de Vos R A, Steur E N, Wevers A, Schütz U, Schröder H
Abstract excerpt
Potential genomic changes leading to decreased nicotine binding, crucial for cognitive dysfunction in Alzheimer's disease (AD), have not yet been studied. A search for mutations of the genes coding for the most widely distributed nicotinic receptor subtype alpha4beta2 (CHRNA4/CHRNB2) has been performed in AD patients by screening the coding regions of both genes by single strand conformation analysis and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
